Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CJRB-101 |
Trade Name | |
Synonyms | CJRB101|CJRB 101 |
Drug Descriptions |
CJRB-101 is a bacterial strain that potentially induces repolarization of M2 to M1 macrophages leading to activation of CD8-positive T-cells and decreased tumor growth (Cancer Res (2023) 83 (7_Supplement): 6433). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C204463 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CJRB-101 | CJRB-101 | 0 | 0 |
CJRB-101 + Pembrolizumab | CJRB-101 Pembrolizumab | 0 | 1 |